Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Glenn Prestwich at University of Utah to Speak at Modern Drug Summit October 24-26 - Glenn Prestwich at University of Utah to Speak at Modern Drug Summit Oct 24-26 in Philadelphia - GTCbio.com
Glenn Prestwich at University of Utah to Speak at Modern Drug Summit October 24-26

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2012/09/26 - Glenn Prestwich at University of Utah to Speak at Modern Drug Summit Oct 24-26 in Philadelphia - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Glenn D. Prestwich, Presidential Professor, Director of Therapeutic Biomaterials Center, and Special Presidential Assistant for Faculty Entrepreneurism of Medicinal Chemistry at the University of Utah Will Give a Plenary Keynote Presentation on “Biomaterials for Regenerative Medicine: From Bench to Business” at the 8th Modern Drug Discovery & Development Summit (October 24-26, 2012 in Philadelphia, PA)

Dr. Glenn Prestwich will describe the entrepreneurial ecosystem at the University of Utah as well as describe a case study for commercialization of a university technology in the area of regenerative medicine.

Clinical biomaterials for regenerative medicine. Injectable and biocompatible vehicles for delivery, retention, growth, and differentiation of progenitor cells are needed for cell therapy. Dr. Glenn Prestwich and his lab have created a synthetic extracellular matrix (sECM) from hyaluronic acid (HA) that affords highly reproducible, manufacturable, approvable, and affordable biomaterials. The technology is being commercialized in three fields of use: human medical devices, cell therapy and research tools for 3-D cell culture, and veterinary wound care and adhesion prevention.

Dr. Glenn D. Prestwich is a Presidential Professor of Medicinal Chemistry and Special Presidential Assistant for Faculty Entrepreneurism at the University of Utah, and he leads the University’s Entrepreneurial Faculty Scholars program. His university research programs include (i) new reagents for lipid signaling in cell biology and cancer treatment, (ii) biomaterials for wound repair, cell therapy, tissue engineering, scar-free healing, and toxicology and xenograft models, and (iii) sulfated glycosaminoglycan analogs as inflammation modulators for clinical use. From these technologies, he co-founded seven start-up companies, including Echelon Biosciences, Inc. (lipid signaling), Carbylan BioSurgery, Inc. (medical devices), Sentrx Animal Care, Inc. (veterinary wound care), Glycosan BioSystems, Inc. (cell therapy and research tools), and GlycoMira Therapeutics, Inc. (anti-inflammatory glycosaminoglycan drugs). He is also President & CEO of Metallosensors, Inc. (real-time mercury detection systems). He received the Governor’s Medal for Science and Technology for 2006, the 1998 Paul Dawson Biotechnology Award and the 2008 Volwiler Research Award of the AACP, the 2010 University of Utah Distinguished Scholarly and Creative Research Award, and the 2010 “Rooster Prize” of the International Society for Hyaluronan Science.

GTC's 8th Modern Drug Discovery and Development Summit features a plenary keynote session followed by five parallel tracks:
• 9th Stem Cell Research and Therapeutics Conference
• 7th Assay and Drug Discovery Technologies Conference
• 4th Translational Medicine Conference
• 3rd Pharmacokinetics and Pharmacodynamics Conference
• Biotechnology Transfer and Commercialization Conference.

For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Glenn Prestwich at University of Utah to Speak at Modern Drug Summit October 24-26

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Persistence Market Research (P) Ltd

Visit  JobsWare.com

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today